Evidence map›Paper›PMID 41529085›Full record

ArticleeLife2026

ATP burst is the dominant driver of antibiotic lethality in

Tejan Lodhiya, Aseem Palande, Anjali Veeram, Gerald J Larrouy-Maumus, Dany J V Beste, Raju Mukherjee

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Polyphosphate synthesis is essential for phosphate and ATP homeostasis during nutrient upshift.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Metabolism-Based Biomarkers for Rapid Phenotypic Antibiotic Susceptibility Testing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tejan LodhiyaDepartment of Biology, Indian Institute of Science Education and Research (IISER), Tirupati, India.ORCID https://orcid.org/0000-0003-4961-1833
Aseem PalandeDepartment of Biology, Indian Institute of Science Education and Research (IISER), Tirupati, India.
Anjali VeeramDepartment of Biology, Indian Institute of Science Education and Research (IISER), Tirupati, India.
Gerald J Larrouy-MaumusCentre for Bacterial Resistance Biology, Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-6614-8698
Dany J V BesteDepartment of Microbial Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.
Raju MukherjeeDepartment of Biology, Indian Institute of Science Education and Research (IISER), Tirupati, India.ORCID https://orcid.org/0000-0003-2035-4407

Funding

Biotechnology and Biological Sciences Research Council BB/T007648/1Dept. of Biotechnology, Govt of India BT/PR20820/MED/30/1875/2017
6 · The paper itself

Abstract

Antibiotic-tolerant bacteria, due to their unique physiology, are refractory to antimicrobial killing and pose challenges for infection control. Incomplete knowledge of how bactericidal antibiotics work limits our understanding of partial resistance due to phenotypic tolerance in mycobacteria, a driver for developing genetic resistance. Using proteomics,

Indexed as

Adenosine TriphosphateAnti-Bacterial AgentsMycobacterium smegmatisCitric Acid CycleDrug Resistance, BacterialMicrobial ViabilityReactive Oxygen SpeciesAdenosine TriphosphateAnti-Bacterial AgentsReactive Oxygen Speciesactinobacteriainfectious diseasemicrobiologymycobacteriumsmegmatis

Identifiers

PMID41529085
PMCPMC12799214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.